Product Description
Bortezomib Injection is a potent medication used to treat multiple myeloma and mantle cell lymphoma by inhibiting proteasomes. Each box contains 10 vials of the synthetic medicine, with each vial containing Bortezomib as its mannitol ester. The recommended dosage is 1.3 mg/m administered intravenously, as directed by an oncologist, typically on specific treatment cycles. It is suitable for adults and should be stored in a refrigerator between 2C and 8C. This anticancer drug is in the form of an injection and is highly recommended for patients with multiple myeloma or certain types of lymphoma.
FAQs of Bortezomib Injection:
Q: What is Bortezomib Injection used for?
A: Bortezomib Injection is used to treat multiple myeloma and mantle cell lymphoma by inhibiting proteasomes.
Q: How should Bortezomib Injection be stored?
A: Bortezomib Injection should be stored in a refrigerator between 2C and 8C. Do not freeze.
Q: What is the recommended dosage for Bortezomib Injection?
A: The recommended dosage is 1.3 mg/m administered as an intravenous injection, as directed by an oncologist.
Q: How many vials are there in each box of Bortezomib Injection?
A: Each box contains 10 vials of Bortezomib Injection.
Q: Who is Bortezomib Injection suitable for?
A: Bortezomib Injection is suitable for adults and is recommended for patients with multiple myeloma or certain types of lymphoma.